Elizabeth K. Lee, MD, a medical oncologist in the gynecologic oncology program at Dana-Farber, presented results from a phase ...

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

Amicus Therapeutics benefits from strong revenue and limited competition. Learn why FOLD stock is a BUY, with a favorable patent settlement and future growth.

Yet another suit alleges an ERISA fiduciary breach regarding the administration of a corporate healthcare plan.

On Monday, 1608 stocks advanced, 2503 declined and 130 remained unchanged on Bombay Stock Exchange with advance decline ratio ...

Dyne is eyeing an accelerated approval filing for DYNE-251 in early 2026 that would pit the asset against Sarepta’s Exondys ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Data from the Phase III MINT trial found that Uplizna demonstrated a greater reduction in Myasthenia Gravis Activities of ...